Patent 11484629 was granted and assigned to Stryker on November, 2022 by the United States Patent and Trademark Office.
Implantable medical devices, such as embolic devices and blood flow filters are disclosed, the devices being made at least partially out of a platinum-tungsten alloy, wherein a percentage of tungsten in the alloy is equal to or greater than about 10% of the alloy by weight.